Simvastatin-ezetimibe and aortic valve stenosis: No benefit with unforeseen harm? José M. Ordovas Clinical Trials Report 24 December 2008 Pages: 3 - 4
Postprandial lipemia, diet, and cardiovascular risk Angela A. RivelleseLutgarda BozzettoGiovanni Annuzzi OriginalPaper 24 December 2008 Pages: 5 - 11
Genomewide association studies and lipid risk factors Ralph BurkhardtEimear E. KennyJan L. Breslow OriginalPaper 24 December 2008 Pages: 12 - 17
Circulating oxidized lipoproteins and cardiovascular risk Hiroyuki Itabe OriginalPaper 24 December 2008 Pages: 18 - 22
Biomarkers of atherosclerosis: Clinical applications Todd M. BrownVera Bittner OriginalPaper 24 December 2008 Pages: 23 - 30
Cardiovascular disease is prevented over the long term by better blood glucose control James B. MeigsFrederick A. Masoudi Clinical Trials Report 24 December 2008 Pages: 33 - 34
Cardiovascular risk-benefit ratio of thiazolidinediones Kasia LipskaSilvio E. Inzucchi OriginalPaper 24 December 2008 Pages: 42 - 50
Microvascular changes in the retina as a risk marker for cardiovascular disease Ning CheungTien Y. Wong OriginalPaper 24 December 2008 Pages: 51 - 58
HIV, insulin resistance and cardiovascular disease Katherine Samaras OriginalPaper 24 December 2008 Pages: 59 - 64
Polycystic ovary syndrome and cardiovascular disease risk Richard S. Legro OriginalPaper 24 December 2008 Pages: 65 - 70
Disease management strategies to optimize cardiovascular risk in type 2 diabetes mellitus Patrick J. O’ConnorJoAnn M. Sperl-HillenThomas E. Kottke OriginalPaper 24 December 2008 Pages: 71 - 77